First patient with peripheral T cell lymphoma dosed with Yingli Pharma’s linperlisib
The first patient has been dosed in a phase 2 trial looking at a drug…
September 5, 2022 - 2 minutes
The first patient has been dosed in a phase 2 trial looking at a drug…